Navigation Links
CONRAD to host HIV symposium at 2nd Annual Antivirals Congress
Date:11/5/2012

Arlington, VA CONRAD HIV and microbicides experts will be featured at the 2nd Annual Antivirals Congress organized by Elsevier publications. This year's conference is being held on November 11-13 at the Boston Marriott Cambridge. Executive and Scientific Director Gustavo Doncel and Director of Product Development David Friend will discuss ex vivo models for testing topical antiviral microbicides and current antiretroviral based microbicide products.

Other speakers at the CONRAD symposium include Tom Hope from Northwestern University and Patrick Kiser from the University of Utah who will speak on defining the interaction of HIV and the mucosal barriers exposed during sexual transmission, and novel microbicide dosage forms to prevent HIV transmission, respectively.

What: CONRAD Symposium: The Use of Antiviral Agents to Prevent HIV Transmission

When and Where: Monday, November 12th 2:00-3:40PM Boston Marriott Cambridge

CONRAD, a not for profit scientific organization based in Arlington, Virginia, specializes in developing new contraceptive methods and products to prevent or reduce HIV and other sexually transmitted infections. Several products in the pipeline focus on multi-purpose prevention options which provide contraception as well as HIV and STI protection. CONRAD tested and developed tenofovir gel, the first drug to show proof of concept that a vaginal gel containing antiretrovirals can reduce HIV and HSV-2 infections when used before and after sex.

Tenofovir is a drug commonly used by those infected with HIV to prevent the virus from multiplying in the immune system. A clinical study of women in South Africa who used a vaginal gel containing tenofovir has shown that it is 40-54 percent effective in reducing sexual transmission when used before and after sex.

The Antiretrovirals Congress provides state-of-the-art reports for scientists, health professionals and non governmental authorities to accelerate progress in the development and application of antivirals. The Congress serves as an interface between different interest groups from academia, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals.


'/>"/>

Contact: Annette Larkin
alarkin@conrad.org
703-772-6427
CONRAD
Source:Eurekalert

Related medicine news :

1. Triple negative breast cancer symposium highlights current advances
2. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
3. Kessler Foundation scientists present cognitive research findings at MS dual symposium
4. fiteBac™ SkinCare, LLC Participates in OSAP Symposium on Infection Control
5. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
6. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
7. Symposium on sustainability to feature three new NJIT faculty
8. Key research from the 2012 Breast Cancer Symposium highlights treatment advances for early breast cancer
9. Leading stem cell scientists to focus on diabetes, eye diseases at Cedars-Sinai symposium
10. Penn Translational Medicine Institute to hold 7th Annual Symposium
11. International symposium will address non-Hodgkins lymphoma in the young
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... Research and Markets has announced the addition ... States, China, Japan, Brazil, United Kingdom, Germany, France, Italy, ... Surgical Procedure Volumes: Global ... surgical procedure volume data in a geographic context. The ... of growth drivers and inhibitors, including world population growth, ...
Breaking Medicine Technology: